FDA authorizes third Johnson & Johnson COVID-19 vaccine batch from troubled Baltimore plant
The Food and Drug Administration on Tuesday announced that it had authorized an additional batch of Johnson & Johnson COVID-19 vaccine that had been produced from a troubled Baltimore facility.